On the one hand,
\nmedical and political authorities the world over are pleading for the rapid
\nvaccination of a significant number of people, which in their vision, is the
\nonly way to contain the present pandemic. On the other hand, one of the
\nvaccines authorized by the European Medicines Agency, the one made by the
\nBritish-Swedish group AstraZeneca has sparked off heated debates. <\/p>\n
\n
\n
\n
<\/p>\n
The EMA
\nannounced a potential connection between the vaccine and rare cases of blood
\nclots in those vaccinated. However, the same agency says the overall benefits
\nof the vaccine in preventing the Covid-19 pandemic outweigh the risks of side
\neffects. The EMA Executive Director Emer Cooke told the BBC quote: This
\nvaccine has proven to be highly effective – it prevents severe disease and
\nhospitalisation, and it is saving lives.<\/p>\n
\n
\n
\n
<\/p>\n
This is the
\nreason for which the European Commissioner for Health, Stella Kyriakides, has
\ncalled on the EU countries to speak with one voice across the EU to improve
\npeople’s trust in vaccination. <\/p>\n
\n
\n
\n
<\/p>\n
Nevertheless,
\nmany states have decided to restrict the use of this vaccine in some age
\nbrackets. So, Britain, which has so far vaccinated over 20 million people with
\nAstraZeneca and has discovered blood clots in 80 cases, has decided to no
\nlonger administer the vaccine to people below 30. According to The Guardian, the recommendation is based on the low risk of
\ndeveloping severe forms of Covid-19 in this age bracket. <\/p>\n
\n
\n
\n
<\/p>\n
In larger groups
\nthough, the vaccine’s overall benefits would outweigh the rare side effects
\nrisks. Just like Britain, Spain, Germany, the Netherlands and Italy have
\nrestricted the use of AstraZeneca vaccine but in patients under 60. Authorities
\nin Romania have decided not to alter its vaccine rollout but are preventing the
\npeople who had thrombosis after the first jab from getting the booster dose
\nwith the same type of vaccine. <\/p>\n
\n
\n
\n
<\/p>\n
At the same time
\nthe medical personnel using the AstraZeneca vaccine must inform patients to see
\na physician if they experience any health issues after getting the jab. The
\nsymptoms that might appear can include abdominal and chest pains, headaches and
\nblurry vision. <\/p>\n
\n
\n
\n
<\/p>\n
One thing’s for
\nsure though, talks over the side effects post vaccination have influenced the
\ndecision of many Romanians on getting this type of vaccine. According to
\nstatistics, one out of three people enlisted for vaccination with AstraZeneca
\nhas withdrawn. <\/p>\n
\n
<\/p>\n
(bill)<\/p>\n
\n
<\/p>\n","protected":false},"excerpt":{"rendered":"
The European Medicines Agency (EMA) has announced a possible connection between the AstraZeneca vaccine against the novel coronavirus and blood clots that might appear in some patients. Nevertheless, EMA says the overall benefits of the vaccine in prevent<\/p>\n","protected":false},"author":109,"featured_media":87433,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[37738],"tags":[35953,36077,36078,40222,32402],"coauthors":[],"class_list":["post-88562","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-today-in-the-news","tag-astrazeneca","tag-blood","tag-clot","tag-cooke","tag-vaccine"],"acf":[],"yoast_head":"\n